Comment on: “Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers”

被引：0
|
作者：
Alessandro Curto
Livio Garattini
机构：
[1] IRCCS Institute for Pharmacological Research ‘Mario Negri’,CESAV, Center for Health Economics
来源：
Applied Health Economics and Health Policy | 2014年 / 12卷 / 5期
关键词：
Public Health; Health Outcome; Outcome Research; Health Economic; International Society;
D O I：
10.1007/s40258-014-0118-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：565 / 565
相关论文
共 37 条
  • [31] Can't Get No Satisfaction? Will Pay for Performance Help? Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products
    Towse, Adrian
    Garrison, Louis P., Jr.
    [J]. PHARMACOECONOMICS, 2010, 28 (02) : 93 - 102
  • [32] ROLE OF CLINICAL PHARMACIST IN OPTIMIZING REIMBURSEMENT ORIGINATING FROM PERFORMANCE-BASED RISK-SHARING ARRANGEMENTS: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL "G. MARTINO" FROM MESSINA, ITALY
    Polimeni, G.
    Isgro, V
    Aiello, A.
    D'Ausilio, A.
    D'Addetta
    Cuzzocrea, S.
    Caputi, A. P.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A756 - A756
  • [33] Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement
    Quinlan, Taryn A. G.
    Schroeder, Brock
    Kwon, Sue
    Barlow, Jane F.
    Sherman, Michael S.
    Anderson, Heather D.
    Wright, Garth
    McQueen, R. Brett
    [J]. PHARMACOECONOMICS-OPEN, 2021, 5 (03) : 449 - 458
  • [34] LINKING PAYMENT AND HEALTH OUTCOMES: A SYSTEMATIC REVIEW AND TAXONOMY OF PERFORMANCE-BASED HEALTH OUTCOMES AGREEMENTS BETWEEN HEALTH CARE PAYERS AND MANUFACTURERS
    Carlson, J. J.
    Sullivan, S. D.
    Garrison, L. P.
    Neumann, P. J.
    Veenstra, D. L.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A90 - A90
  • [35] Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement
    Taryn A. G. Quinlan
    Brock Schroeder
    Sue Kwon
    Jane F. Barlow
    Michael S. Sherman
    Heather D. Anderson
    Garth Wright
    R. Brett McQueen
    [J]. PharmacoEconomics - Open, 2021, 5 : 449 - 458
  • [36] AGREEMENT BETWEEN FDA APPROVED DRUG LABEL AND PERFORMANCE BASED RISK-SHARING ARRANGEMENT ENDPOINTS
    Pham, N. N.
    Carlson, J. J.
    [J]. VALUE IN HEALTH, 2018, 21 : S119 - S119
  • [37] THE ROLE OF PERFORMANCE-BASED RISK-SHARING AGREEMENTS IN MINIMISING PAYER UNCERTAINTY WHEN STANDARD OF CARE IS NOT CLEARLY DEFINED; THE EXAMPLE OF CROHN'S DISEASE RELATED COMPLEX PERIANAL FISTULAS
    Schmetz, A.
    Kaur, S.
    Petrakis, I
    Agboton, C.
    Zouraq, Azzabi, I
    Minda, K.
    Rawson, K.
    Campbell-Hill, S.
    Baumgart, D. C.
    [J]. VALUE IN HEALTH, 2018, 21 : S148 - S148
1234